tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ALLO Stock Latest News

Airbnb, Moderna report Q4 results: Morning Buzz
The FlyAirbnb, Moderna report Q4 results: Morning Buzz
2d ago
BA
AMD
Allogene publishes data from ALPHA, ALPHA2 trials of cemacabtagene ansegedleucel
PremiumThe Fly
Allogene publishes data from ALPHA, ALPHA2 trials of cemacabtagene ansegedleucel
3d ago
ALLO
Allogene Therapeutics Announces Executive Departure and Transition
PremiumCompany Announcements
Allogene Therapeutics Announces Executive Departure and Transition
19d ago
8K
ALLO
Allogene Therapeutics appoints Beneski as SVP, CTO
PremiumThe Fly
Allogene Therapeutics appoints Beneski as SVP, CTO
19d ago
ALLO
Allogene announces FDA cleared IND application for study of ALLO-329
PremiumThe Fly
Allogene announces FDA cleared IND application for study of ALLO-329
20d ago
ALLO
Allogene acknowledges passing of founding board member David Bonderman
PremiumThe FlyAllogene acknowledges passing of founding board member David Bonderman
2M ago
ALLO
JPMorgan healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
2M ago
ALLO
IGMS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ACAD
AKBA
Allogene Therapeutics presents data for ALLO-329 in autoimmune disease
PremiumThe Fly
Allogene Therapeutics presents data for ALLO-329 in autoimmune disease
3M ago
ALLO
Allogene Therapeutics price target lowered to $9 from $11 at Piper Sandler
PremiumThe Fly
Allogene Therapeutics price target lowered to $9 from $11 at Piper Sandler
3M ago
ALLO
Allogene Therapeutics Advances CAR T Therapies
PremiumCompany Announcements
Allogene Therapeutics Advances CAR T Therapies
3M ago
ALLO
Allogene Therapeutics reports Q3 EPS (32c), consensus (33c)
PremiumThe Fly
Allogene Therapeutics reports Q3 EPS (32c), consensus (33c)
3M ago
ALLO
Allogene announces Phase 1 data on ALLO-316 in advanced RCC
PremiumThe FlyAllogene announces Phase 1 data on ALLO-316 in advanced RCC
3M ago
ALLO
Allogene Therapeutics to present data on ALLO-316 at IKCS, SITC meetings
Premium
The Fly
Allogene Therapeutics to present data on ALLO-316 at IKCS, SITC meetings
3M ago
ALLO
Allogene Therapeutics receives FDA RMAT designation for ALLO-316
Premium
The Fly
Allogene Therapeutics receives FDA RMAT designation for ALLO-316
4M ago
ALLO
Is ALLO a Buy, Before Earnings?
PremiumPre-Earnings
Is ALLO a Buy, Before Earnings?
4M ago
ALLO
Artiva Biotherapeutics appoints Alison Moore, Ph.D., to Its Board of Directors
PremiumThe Fly
Artiva Biotherapeutics appoints Alison Moore, Ph.D., to Its Board of Directors
4M ago
ALLO
ARTV
Allogene to present pre-clinical data for next-gen AlloCAR T candidate
PremiumThe Fly
Allogene to present pre-clinical data for next-gen AlloCAR T candidate
5M ago
ALLO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
OGI
ALLO
Allogene Therapeutics price target raised to $8 from $7 at Citi
PremiumThe FlyAllogene Therapeutics price target raised to $8 from $7 at Citi
6M ago
ALLO
Allogene Therapeutics price target lowered to $14 from $35 at Canaccord
Premium
The Fly
Allogene Therapeutics price target lowered to $14 from $35 at Canaccord
6M ago
ALLO
Allogene Therapeutics assumed with an Outperform at Oppenheimer
Premium
The Fly
Allogene Therapeutics assumed with an Outperform at Oppenheimer
6M ago
ALLO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >